#  Message from the Editor-in-Chief 

 



 ##  

  expand\_more  

 
  

 

 Dear Colleagues,

 In this issue of *eye Insights,* we take a close look at idiopathic intracranial hypertension (IIH). Inside, you’ll find key information about how IIH is diagnosed and treated as well as further reading.

 IIH is becoming more prevalent due to increasing rates of obesity in the United States. Undiagnosed patients are at risk for visual loss, but treatment is widely available and effective. Neuro-ophthalmologists have the expertise to diagnose and treat IIH, but effective treatment requires coordinated management with additional specialists, including internists, nutritionists, and neurosurgeons.

 There are about 200 full-time neuro-ophthalmologists nationwide. For a list of doctors who specialize in neuro-ophthalmology, please visit the website for the North American Neuro-Ophthalmology Society.

 e hope you find this issue of *eye Insights* useful in your practice. Back issues are available online at masseyeandear.org. If you have questions or comments, please email us at <eyeinsights@meei.harvard.edu>.

   ![Headshot of Joan W. Miller, MD](/sites/g/files/omnuum9886/files/styles/hwp_1_1__360x360_scale/public/eye/files/miller_joan_2018_preferred_0.jpg?itok=oRmV6wJy) 

 

**Joan W. Miller, MD** *David Glendenning CoganProfessor of Ophthalmology and Chair, Department of Ophthalmology, Harvard Medical School*

 *Chief of Ophthalmology, Massachusetts Eye and Ear and Massachusetts General Hospital*

 *Ophthalmologist-in-Chief, Brigham and Women’s Hospital*